Get Started Free
Home›Healthcare›Agilent Technologies
Agilent Technologies logo
Agilent Technologies
Healthcare

Agilent Technologies Company Overview

Agilent Technologies logo

Agilent Technologies

● Active
Healthcare · Santa Clara, CA · Est. 1999
Life SciencesDiagnosticsInstrumentationChemical AnalysisSaaS↗ Website
$24.5B
Valuation
$6.8B
Revenue
18k+
Employees
1999
Founded

Agilent Technologies is a global leader in life sciences, diagnostics, and applied chemical analysis, providing instruments, software, services, and consumables for laboratories worldwide. Its customers include pharmaceutical companies, academic research institutions, environmental labs, and food safety organizations that rely on Agilent's measurement science for analysis, testing, and compliance workflows.

Recent Press
5 items
Award·2025-11-18
Agilent Technologies Named to Dow Jones Sustainability World Index for 14th Consecutive Year
Agilent Technologies was included in the Dow Jones Sustainability World Index (DJSI) for the 14th consecutive year, ranking in the top 10% of companies globally in the Pharmaceuticals, Biotechnology & Life Sciences Equipment sector for ESG performance.
Press Release·2025-08-27
Agilent Reports Third-Quarter Fiscal Year 2025 Financial Results
Agilent reported Q3 FY2025 revenue of $1.74 billion, exceeding guidance with 10.1% reported growth and 6.1% core growth year-over-year, with non-GAAP EPS of $1.37.
Product Launch·2025-08-20
Agilent Expands PFAS Testing Portfolio with New Targeted and Suspect Screening LC/MS Solutions
Agilent launched an expanded portfolio of PFAS analysis solutions including the Agilent PFAS Master Method and Unlimited PFAS Screening workflow for the 6495 Triple Quadrupole and 6546 Q-TOF, addressing EPA Method 533 and 537.1 requirements for drinking water testing labs.
Press Release·2025-05-28
Agilent Reports Second-Quarter Fiscal Year 2025 Financial Results
Agilent reported Q2 FY2025 revenue of $1.67 billion, up 6.0% year-over-year on a reported basis and 5.3% core growth, with non-GAAP EPS of $1.31, up 7% from Q2 2024.
Partnership·2025-05-14
Agilent and Bruker Announce Spatial Biology Partnership for Multiomics Workflows
Agilent Technologies and Bruker announced a collaboration to integrate Agilent's SurePrint in situ hybridization probes with Bruker's CODEX spatial proteomics platform, enabling co-registered spatial transcriptomics and proteomics in a single tissue section for oncology research.
Company History
9 milestones
Agilent Technologies was created as HP's electronic measurement and life sciences spin-off, taking with it HP's test & measurement, semiconductor, chemical analysis, and healthcare businesses in an $8.4B IPO — the largest US tech IPO of 1999.

Agilent Technologies Organization Structure & Team

Org Chart
18,100 employees · Click a leader to explore their team
13,880 across 12 departments
Chief Executive Officer
Mike McMullen
Bob McMahon — Departments
· 13880 people across 12 depts

Agilent Technologies Financials, Revenue & Market Share

Annual Revenue
$6.8B
+7.2% vs prior year
YoY Growth
+7.2%
From $6.32B to $6.8B
Revenue / Employee
$376K
Annual revenue per full-time employee
Revenue Growth
2021
2022
2023
2024
2025
$6.32B
$6.85B
$6.83B
$6.33B
$6.8B
Market Share
Analytical Laboratory Instruments (global)
8%
share
Agilent Technologies
8%
Thermo Fisher Scientific
28%
Waters Corporation
9%
Shimadzu Corporation
7%
PerkinElmer
5%
$95B
TAM
$38B
SAM
$6.8B
SOM
Revenue Streams
Instruments & Systems55%
Services & Support25%
Consumables & Software20%
Business Units
Life Sciences & Applied Markets55%
Instruments and consumables for pharmaceutical R&D, clinical research, food safety, and environmental testing — including the InfinityLab LC, 6495 MS, Seahorse XF Analyzer, and SureSelect genomics.
Diagnostics & Genomics22%
Cancer diagnostics reagents, FISH probes, SurePrint microarrays, and companion diagnostic solutions — sold to clinical pathology labs and oncology research institutions.
Agilent CrossLab23%
Enterprise-wide services including instrument qualification, OpenLAB software licenses, training programs, and lab management consulting — providing predictable subscription-like recurring revenue.

Agilent Technologies Internal Tools & Processes

Internal Tools
12 departments
Chromatography & Mass Spectrometry R&D1800 people · 3 roles
Standards & Certifications
10 standards
Compliance frameworks, security audits, and quality certifications this company maintains.
Quality
ISO 9001:2015
Certified
Agilent's global manufacturing sites — including Santa Clara, Waldbronn Germany, and Penang Malaysia — are ISO 9001:2015 certified, ensuring that Agilent's instrument design, manufacturing, and service delivery processes meet international quality management standards expected by pharmaceutical and regulated lab customers.
Quality
ISO 13485
Certified
Agilent holds ISO 13485 certification for its Diagnostics & Genomics division, covering the design and manufacture of in vitro diagnostic (IVD) reagents, FISH probes, and companion diagnostic products supplied to clinical pathology labs that require medical device quality management system compliance.
Regulatory
21 CFR Part 11
Compliant
Agilent's OpenLAB CDS and MassHunter software platforms are designed and validated to comply with FDA 21 CFR Part 11 requirements for electronic records and electronic signatures, enabling pharmaceutical and biotech customers to use Agilent data systems in GMP-regulated analytical environments.
Regulatory
EU Annex 11
Compliant
Agilent supports EU GMP Annex 11 computerized systems compliance through its OpenLAB CDS validation documentation, audit trail functionality, and data integrity controls — critical for Agilent pharmaceutical customers submitting to EMA and conducting clinical trials in the European Union.
Environmental
ISO 14001:2015
Certified
Agilent Technologies operates under ISO 14001:2015 environmental management certification across its major manufacturing facilities, reflecting Agilent's commitment to reducing chemical waste, energy consumption, and greenhouse gas emissions associated with analytical instrument production.
Environmental
RoHS / REACH
Compliant
Agilent ensures all instruments and reagents sold in the EU comply with RoHS restrictions on hazardous substances and REACH chemical registration requirements, providing safety data sheets and substance declarations to support customer supply chain compliance programs.
Regulatory
ITAR / EAR
Compliant
Agilent complies with U.S. International Traffic in Arms Regulations (ITAR) and Export Administration Regulations (EAR) for export of dual-use analytical instruments and technologies, maintaining an export compliance program that covers GC, LC/MS, and spectroscopy products shipped to controlled-country customers.
Security
SOC 2 Type II
Certified
Agilent's cloud-hosted OpenLAB CDS Enterprise and CrossLab Connect remote monitoring platform are audited under SOC 2 Type II to verify controls over security, availability, and confidentiality of customer laboratory data — a requirement for pharmaceutical companies using SaaS-based lab informatics.
Safety
OSHA Process Safety
Compliant
Agilent's manufacturing sites that handle high-pressure gas systems and compressed gas cylinders comply with OSHA Process Safety Management (29 CFR 1910.119) standards, ensuring safe handling of industrial gases used in instrument testing and calibration at Agilent's California and Delaware facilities.
Regulatory
CLIA Compliance
Compliant
Agilent's in vitro diagnostic products sold for use in U.S. clinical laboratories are designed to support customer compliance with the Clinical Laboratory Improvement Amendments (CLIA), covering diagnostic test performance standards for sensitivity, specificity, and reportable range that clinical lab customers must demonstrate to CMS.

Agilent Technologies Interview Preparation

Interview Prep
Role-specific interview questions and keywords. Select a department, then click any role to prepare.
Chromatography & Mass Spectrometry R&D· 3 roles

Agilent Technologies Products & Competitors

Product Suite
5 products · select one to explore
Healthcare
Analytics
Agilent InfinityLab LC System
The gold standard for high-performance liquid chromatography

The Agilent InfinityLab LC System is a modular HPLC/UHPLC platform designed for pharmaceutical QC, bioanalytical, and environmental labs requiring precision separation science. It supports a wide range of detector configurations and column chemistries and integrates with OpenLAB CDS for compliant data management.

Use Cases
Performing USP method validation for small-molecule API purity in pharmaceutical QC labsRunning gradient UHPLC separation of biopharmaceutical peptide maps for biosimilar characterizationAutomating environmental water sample analysis for EPA 524.4 volatile organic compound compliance
No image
Key Customers
PFE
Pfizer
SGS
SGS Group
ERF
Eurofins Scientific
Competitive Intelligence
VSWaters ACQUITY UPLC
THEM

Waters ACQUITY UPLC is a high-throughput ultra-performance liquid chromatography system built on Waters' proprietary 1.7-micron BEH particle technology, designed for fast pharmaceutical separations with sub-2-minute run times and seamless Empower 3 software integration.

EDGE

Wider column portfolio with Poroshell 120 and RRHD bonding chemistry for superior bio-separations

VSShimadzu Nexera X3
THEM

The Shimadzu Nexera X3 is an ultra-high-speed UHPLC system featuring a new quaternary pump design with an integrated micro-fluidic degasser, supporting flow rates up to 5 mL/min and sub-minute cycle times for high-throughput screening.

EDGE

Broader detector integration including triple-quadrupole MS through a single Agilent MassHunter software environment

VSThermo Fisher Vanquish
THEM

Thermo Fisher's Vanquish UHPLC is a pressure-rated system supporting up to 1,500 bar with an intelligent detector flow cell, aimed at metabolomics and proteomics workflows in academic and pharma research labs.

EDGE

Deeper pharmaceutical regulatory compliance tools including OpenLAB CDS 21 CFR Part 11 audit trails out of the box

Related Companies

Eli Lilly logo
Eli Lilly
Healthcare
Eli Lilly is a global pharmaceutical company that discovers, develops, and markets medicines across diabetes, oncology, immunology, and neuroscience. Its GLP-1 receptor agonist portfolio — Mounjaro (tirzepatide) for type 2 diabetes and Zepbound for obesity — drove record revenue growth and positioned Lilly as one of the world's most valuable pharmaceutical companies.
Abbott Laboratories logo
Abbott Laboratories
Healthcare
Abbott Laboratories is a global healthcare company that develops and manufactures medical devices, diagnostics, nutrition products, and branded generic pharmaceuticals. Its portfolio spans the FreeStyle Libre continuous glucose monitoring system — the world's most-used CGM — alongside cardiac devices, point-of-care diagnostics, and infant nutrition brands across 160 countries.
Thermo Fisher Scientific logo
Thermo Fisher Scientific
Healthcare
Thermo Fisher Scientific is the world's largest life sciences company, providing analytical instruments, reagents, consumables, software, and services for scientific research, bioprocessing, clinical diagnostics, and pharmaceutical manufacturing. With over $44B in annual revenue, Thermo Fisher serves pharmaceutical and biotech companies, academic research institutions, clinical laboratories, and government agencies with an unmatched portfolio spanning mass spectrometry, chromatography, cell culture, genetic analysis, and laboratory equipment.
Medtronic logo
Medtronic
Healthcare
Medtronic is the world's largest standalone medical device company, developing therapies and diagnostics across cardiac rhythm management, surgical robotics, neuromodulation, diabetes technology, and endoscopy. Its portfolio spans implantable cardiac monitors, transcatheter pacemakers, robotic surgery platforms, and closed-loop insulin delivery systems used in over 150 countries.
Stryker Corporation logo
Stryker Corporation
Healthcare
Stryker is one of the world's leading medical technology companies, offering a broad portfolio of innovative products and services in orthopedics, medical and surgical equipment, and neurotechnology. The company serves surgeons, hospitals, and healthcare systems across 75 countries with products ranging from joint replacement implants and surgical robots to emergency medical equipment.
Johnson & Johnson logo
Johnson & Johnson
Healthcare
Johnson & Johnson is one of the world's largest healthcare companies, operating across two segments — Innovative Medicine, which develops and markets prescription pharmaceuticals for oncology, immunology, neuroscience, and cardiovascular diseases, and MedTech, which produces surgical robotics, orthopedics, cardiovascular devices, and vision care products. After spinning off its consumer health division as Kenvue in 2023, J&J focuses exclusively on innovative medicine and medical technology.